Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach
Robert Frank Cornell, Parameswaran Hari, William R Drobyski
BMJ Case Reports
|
November 27, 2019
Rare case of non-producer variant of plasma cell dyscrasias with circulating plasma cells
Sukesh Manthri, Rabia Zafar, Robert Frank Cornell, et al.
British Journal of Haematology
|
July 6, 2018
Second primary malignancy after multiple myeloma-population trends and cause-specific mortality
Luciano J Costa, Kelly N Godby, Saurabh Chhabra, et al.
Frontiers in Oncology
|
March 16, 2019
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Robert Frank Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
American Journal of Hematology
|
April 26, 2019
Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
Noa Biran, David Siegel, Jesus G Berdeja, et al.
Case Reports in Endocrinology
|
January 24, 2014
Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency
Robert Frank Cornell, Daniel F Kelly, Gal Bordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2017
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis
Oluchi Oke, Tarsheen Sethi, Stacey Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
Robert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2018
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
Dan T Vogl, David Dingli, Robert Frank Cornell, et al.
BMC Cancer
|
September 7, 2021
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Gabriel Tremblay, Patrick Daniele, Janis Breeze, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach
Robert Frank Cornell, Parameswaran Hari, William R Drobyski
BMJ Case Reports
|
November 27, 2019
Rare case of non-producer variant of plasma cell dyscrasias with circulating plasma cells
Sukesh Manthri, Rabia Zafar, Robert Frank Cornell, et al.
British Journal of Haematology
|
July 6, 2018
Second primary malignancy after multiple myeloma-population trends and cause-specific mortality
Luciano J Costa, Kelly N Godby, Saurabh Chhabra, et al.
Frontiers in Oncology
|
March 16, 2019
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Robert Frank Cornell, Samuel Z Goldhaber, Brian G Engelhardt, et al.
American Journal of Hematology
|
April 26, 2019
Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
Noa Biran, David Siegel, Jesus G Berdeja, et al.
Case Reports in Endocrinology
|
January 24, 2014
Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency
Robert Frank Cornell, Daniel F Kelly, Gal Bordo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2017
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis
Oluchi Oke, Tarsheen Sethi, Stacey Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
Robert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2018
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
Dan T Vogl, David Dingli, Robert Frank Cornell, et al.
BMC Cancer
|
September 7, 2021
Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
Gabriel Tremblay, Patrick Daniele, Janis Breeze, et al.
Page
of 2